1. Is the replacement strategy, as it exists today in the EU for cosmetics, the way forward ?

   • Vera Rogiers

   Editorial 29 April 2011 Pages: 363 - 364

2. Towards an integrated in vitro strategy for repeated dose toxicity testing

   • Tamara Vanhaecke
   • Marleen Pauwels
   • Vera Rogiers

   Editorial 22 April 2011 Pages: 365 - 366

   

3. Alternative (non-animal) methods for cosmetics testing: current status and future prospects—2010

   • Sarah Adler
   • David Basketter
   • José-Manuel Zaldivar

   Review Article 01 May 2011 Pages: 367 - 485

   

4. Persistence of deposited metals in the lungs after stainless steel and mild steel welding fume inhalation in rats

   • James M. Antonini
   • Jenny R. Roberts
   • David G. Frazer

   Inorganic Compounds 06 October 2010 Pages: 487 - 498

   

5. Acrolein, an I-κBα-independent downregulator of NF-κB activity, causes the decrease in nitric oxide production in human malignant keratinocytes

   • Ki-Young Moon

   Molecular Toxicology 02 October 2010 Pages: 499 - 504

   

6. Study on species differences in nephropathy induced by FYX-051, a xanthine oxidoreductase inhibitor

   • Takeo Shimo
   • Naoki Ashizawa
   • Osamu Nagata

   Organ Toxicity and Mechanisms 10 October 2010 Pages: 505 - 512

   

7. Role of cytochrome P450c17α in dibromoacetic acid-induced testicular toxicity in rats

   • Tracy L. Carr
   • Rita Ciurlionis
   • Eric A. G. Blomme

   Organ Toxicity and Mechanisms 03 November 2010 Pages: 513 - 523

   

8. In vivo and in vitro assessment of the role of glutathione antioxidant system in anthracycline-induced cardiotoxicity

   • Anna Vávrová
   • Olga Popelová
   • Tomáš Šimůnek

   Organ Toxicity and Mechanisms 03 November 2010 Pages: 525 - 535